Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ralfinamide

Known as: PRIRALFINAMIDE 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract Neuropathic pain is among the most common and difficult‐to‐treat types of chronic pain and is associated with sodium… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • table 1
Is this relevant?
2016
2016
The α-aminoamide family of sodium ion channel blockers have exhibited analgesic effects on neuropathic pain. Here, a series of… Expand
  • table 1
  • table 1
  • table 2
Is this relevant?
2012
2012
Ralfinamide, an original Na+ channel blocker developed for the treatment of chronic pain, inhibits monoamineoxidase-B with no… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
Ralfinamide is an α-aminoamide derivative with ion channel blocking properties, acting both peripherally and centrally through… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2010
2010
The development of the selective cyclooxygenase 2 (COX-2) inhibitors and their infamous fall from grace accelerated… Expand
Is this relevant?
2008
2008
Ralfinamide is analgesic when applied as a single dose in rodent models of stimulus-evoked chronic pain. However, it is unknown… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Recent studies revealed that ralfinamide, a Na(+) channel blocker, suppressed tetrodotoxin-resistant Na(+) currents in dorsal… Expand
Is this relevant?
2005
2005
Tetrodotoxin-resistant and tetrodotoxin-sensitive Na+ channels contribute to the abnormal spontaneous firing in dorsal root… Expand
Is this relevant?
2004
2004
 
Is this relevant?